The Bank of England will expand its quantitative easing program at next week’s meeting, according to the Standard Chartered research team, which points out to a division in the committee about the effectiveness of negative interest rates.
“We expect the Bank of England (BoE) to announce an additional GBP 100bn of QE purchases on 5 November given the deterioration in the economic environment stemming from new COVID-19 restrictions; such an announcement would take the target to GBP 845bn. “
“Monetary Policy Committee (MPC) members remain divided over the effectiveness of taking rates negative, and a review into their potential use is unlikely to be completed until December at the earliest. Given the lack of consensus between MPC members, negative rates will likely be resisted this year barring significant economic or financial deterioration, either as the result of a shift to full national lockdown, a no-deal Brexit outcome and/or greater-than-expected easing by the European Central Bank (ECB).”
“We think the February 2021 meeting is the more likely time for a cut to negative, particularly if the Brexit aftermath (even with a deal) and COVID impact prove worse than expected.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.